Australia's Healius rejects $1 bln buyout offer by Australian Clinical Labs

Australian Clinical Labs

04/05/2023 24:10

May 4 (Reuters) - Australia's medical centre operator Healius  HLS.AX  on Thursday
recommended that its shareholders reject the A$1.52 billion ($1.01 billion) all-share takeover
offer by Australian Clinical Labs  ACL.AX .
    The offer, made in March, has "no cash and no premium" and is "plainly inadequate", Healius
said in its statement.
    

($1 = 1.5047 Australian dollars)

 (Reporting by Savyata Mishra in Bengaluru; Editing by Shailesh Kuber)
 ((Savyata.Mishra@thomsonreuters.com;))